Resident Posters

(9-001) Medication Use Evaluation of Cangrelor

(9-002) Medication Use Evaluation of Poractant Alfa

(9-003) Identifying Causes of Therapeutic Inertia in Veterans with Uncontrolled Diabetes at a Rural Veteran Affairs Clinic

(9-004) Analysis of Factors Affecting Nonadherence to Guideline-Directed Medical Therapy in Veterans with Uncontrolled Hypertension

(9-005) Evaluating the Impact of a Pharmacogenomics Elective on Student Pharmacist Perceptions, Attitudes, and Preparedness to Implement Pharmacogenomics

(9-006) Assessment of Patient Outcomes from a Pharmacist-led Interprofessional Transitions of Care Program: The ICARE Program

(9-007) Evaluation of Compliance with the Three Hour Early Management Bundle for Sepsis in the Emergency Department

(9-008) Effects of the Addition of Tranexamic Acid to the Massive Transfusion Protocol

(9-009) Impact of Milrinone on Neonates with Persistent Pulmonary Hypertension

(9-010) Retrospective Medication Use Evaluation of Octreotide in a Community Hospital

(9-011) Development, Implementation, and Evaluation of a Weight-Based Enoxaparin Dosing and Anti-Xa Monitoring Program in Trauma Patients at a Large Community Hospital

(9-012) Evaluating the Use of Albumin at a Large Community Hospital

(9-013) Retrospective Evaluation of Glucagon Usage in the Emergency Department at a Community Hospital

(9-014) Retrospective Evaluation of the Use of Intravenous Acetylcysteine at a Community Hospital

(9-015) Evaluation of Pharmacist-directed Heparin Infusion Management

(9-016) Impact of Pharmacist Involvement on the Appropriate Dosing of Ketamine and Propofol During Procedural Sedations in the Emergency Department

(9-018) Evaluating the Implementation of Pharmacist-Driven Enoxaparin Dosing Protocols and Anti-Xa Level Monitoring

(9-019) Evaluation of the Impact of Sodium-Glucose Co-Transporter-2 Inhibitors on Anion Gap Acidosis in Patients Undergoing Cardiovascular Surgery

(9-020) Evaluation of Cost and Efficacy of Patiromer and Sodium Zirconium Cyclosilicate in a Large Community Hospital

(9-021) Medication Use Evaluation of Inhaled Epoprostenol for Acute Respiratory Distress Syndrome in a Large Community Hospital

(9-022) Evaluation of Lorazepam Use for Seizure Termination in the Emergency Department

(9-023) Impact of the Removal of Medications from the Automatic Verification Process in the Emergency Department at a Large Community Hospital

(9-024) Evaluation of a Pharmacy Led MRSA Nasal PCR Protocol on Pneumonia Therapy

(9-025) Analysis of a High-dose Methotrexate Process at a Large Community Hospital

(9-026) Optimization of Inpatient Granulocyte Colony Stimulating Factor Use at a Large Community Hospital

(9-027) Analysis of the Medical Management of Unattached Dialysis Patients After Implementation of Standardized Practices

(9-028) Vecuronium Continuous Infusion versus Intermittent Push in the Management of Adults with Acute Respiratory Distress Syndrome

(9-029) Utilization of Famotidine for Stress Ulcer Prophylaxis and Associated Outcomes in a Community Hospital

(9-030) Implementation and Assessment of an Emergency Department Blood Culture Follow-up Protocol Post-hospital Discharge

(9-031) Impact of Pharmacist-Led Interventions on Urine Cultures and Sexually Transmitted Infections in the Emergency Department

(9-032) Accelerated Physician Notification of Positive Clostridioides Difficile Result: An Analysis

(9-033) Outcomes Associated with Vancomycin-Resistant Enterococci and Non-Vancomycin-Resistant Enterococcal Urinary Tract Infections Across a Community-based Health System

(9-034) Assessing the Value of Pharmacist-led Education of Chemotherapy Regimens Using Surveys to Measure Patient Satisfaction and Understanding

(9-035) Quality Improvement in Prior to Admission Medication Reconciliation: Evaluation of the Accuracy of Admission Medication Reconciliation

(9-036) Assessment of Heparin Twice Daily versus Three Times Daily for Venous Thromboembolism Prevention

(9-037) Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Obesity

(9-038) Evaluation of Albumin and Loop Diuretic Combination Therapy for Deresuscitation in Critically Ill Patients with Hypoalbuminemia

(9-039) Impact of Implementation of a Rapid Molecular Diagnostic Platform on Time to Effective Antibiotics in a Community Teaching Hospital

(9-040) Impact of a Pharmacist-Driven Continuous Glucose Monitoring Clinic on Financial and Clinical Outcomes in a Federally Qualified Health Center

(9-042) Benefit of a Pharmacist Led Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) Service in a Family Medicine Clinic

(9-043) Safety and Efficacy of Once-daily versus Twice-daily Insulin Glargine in Acutely Ill Medical Patients at an Academic Medical Center

(9-044) Identification of Risk Factors for Methicillin-Resistant Staphylococcus aureus Community-Acquired Pneumonia at an Academic Medical Center

(9-045) Impact and Effect on Patient Biomarkers and Adherence of a Community Pharmacist-Led Type II Diabetes Mellitus Management Program, a Pre- and Post-Pandemic Examination

(9-046) A Retrospective Review of Carbapenem Use in Urinary Tract Infections at Banner Health Facilities

(9-047) Efficacy and Safety Outcomes of Implementing a Pharmacist-Driven Warfarin Management Collaborative Practice in the Acute Care Setting

(9-048) Preoperative Renin-Angiotensin System Inhibition in Cardiothoracic Surgery

(9-049) Retrospective Chart Review of Ceftriaxone Utilization for the Empiric Treatment of Urinary Tract Infections in Admitted Patients at a Large Community Hospital

(9-050) Retrospective Review of Rasburicase Utilization in Pediatric and Adult Patients Across a Large Health System

(9-051) Assessing the Use of Potentially Inappropriate Medications in Patients with Chronic Kidney Disease

(9-052) Assessment of Hyponatremia Management at a Community Hospital

(9-053) Evaluation of Heparin Infusion Dosing Utilizing Actual Body Weight in Obese versus Non-Obese Patients

(9-054) Total Usage of Meropenem Before and After Implementation of Provider Selected Antibiotic Indication Requirements

(9-055) Retrospective Comparison of Low Dose versus Standard Dose Unfractionated Heparin and Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Underweight, Hospitalized Patients

(9-056) Impact on Patient Care After Implementing an Electronic Order Set Based on the New Clostridioides Difficile Guidelines

(9-057) Optimizing Outcomes in Alcohol Withdrawal: Phenobarbital vs. Short Acting Benzodiazepines vs. Long-Acting Benzodiazepines

(9-058) Evaluating Outcomes of a Pharmacist Led Heart Failure Collaborative Practice to Reduce Hospitalizations and Improve Quality Measures Within a Community Health Network

(9-059) Evaluation of Embedding Clinical Decision Support in Heparin-Induced Thrombocytopenia (HIT) Testing

(9-060) Evaluation of Tolvaptan Usage at Kingman Regional Medical Center

(9-061) Evaluation of Methylnaltrexone for Opioid-Induced Constipation

(9-062) Quality Assurance and Initiative: Implementation of a Quality Assurance Process Within a Community Health Clinic Pharmacy

(9-063) Implementing a Quality Improvement Process to Track Errors at a Rural Federally Qualified Health Center Pharmacy

(9-064) Evaluation of a Potassium Replacement Protocol in Non-Intensive Care Unit Inpatients

(9-065) Frequency of Point-of-Care Blood Glucose (POC-BG) Testing in Adult Patients on Total Parenteral Nutrition (TPN)

(9-066) Impact of Clinical Assessments Completed via Text Message in Patients with Multiple Sclerosis in a Large Specialty Pharmacy

(9-067) Effect of Patient Attributes on Optimal Adherence for Oral Oncology Therapies

(9-068) Impact of Social Determinants of Health on Multiple Sclerosis Adherence, Persistence, and Patient Reported Outcomes for Patients Using a National Mail-order Specialty Pharmacy

(9-069) Assessing the Real-world Impact of Biosimilar Availability on Patient and Payer Costs and Patient Clinical Outcomes

(9-070) Impact of an Integrated Care Model Using Specialty Pharmacy Services to Evaluate Patient’s Medication Adherence and Persistence

(9-071) Evaluating the Impact of Pharmacists’ Interventions on Antiretroviral Therapy Proportion of Days Covered Scores Within a Community Pharmacy Medication Therapy Management Program

(9-072) Levels of Albumin and Impact on Loop Diuretic and Albumin Co-administration in Heart Failure (LILAC-HF)

(9-073) Outcomes of Empiric Doxycycline Therapy for Outpatient Treatment of Confirmed or Suspected Streptococcus Skin and Soft Tissue Infection

(9-074) Evaluating the Efficacy and Safety of Letermovir Compared to Valganciclovir for the Prevention of Human Cytomegalovirus Disease in Adult Lung Transplant Recipients

(9-075) Impact of a Once Weekly Glucagon-like Peptide-1 Receptor Agonist on Insulin Dose and Injection Burden in a Federally Qualified Health Center

(9-076) Long History of Hirsutism in Postmenopausal Woman with Steroid Cell Tumor of the Ovary: A Case Report

(9-077) Observational Study on the Incidence of Inappropriate Anaerobic and Antipseudomonal Coverage in Empiric Treatment of Pneumonia

(9-078) Analysis of Patient Adherence to Filling Emergency Department Discharge Prescriptions for the Empiric Treatment of Chlamydia Trachomatis Infection

(9-079) Evaluating the Impact of a Professional Skills Development Workshop on Pharmacy Students’ Knowledge and Confidence in Prescribing Nirmatrevir/Ritonavir for COVID-19 Management in Community Pharmacy Settings

(9-080) Evaluation of Levetiracetam Loading Dose Use for Status Epilepticus in the Emergency Department of a Rural Community Hospital

(9-081) Evaluation of Dosing Appropriateness of Apixaban in Non-Valvular Atrial Fibrillation for Prevention of Cardioembolic Stroke in a Rural Community Hospital

(9-082) Retrospective Study of the Impact of Pharmacy Services on Hepatitis C (HCV) Outcomes

(9-083) Cross-Sectional Study of Provider Attitudes Toward Prescribing HIV Pre-Exposure Prophylaxis for Patients in a Federally Qualified Health Center

(9-084) Impact of Clinical Pharmacist Interventions on Asthma Control in a Federally Qualified Health Center

(9-085) Certified Pharmacy Technicians as Patient Navigators in Hepatitis C Linkage-to-Care Services

(9-086) Evaluation of Continuation of Prior-to-Admission Antidepressants on Sedation Related Outcomes in Mechanically Ventilated Patients

(9-087) Beta-Agonist Sparing versus Rate Slowing Therapy in Septic Patients with Tachyarrhythmia

(9-088) Medication Use Evaluation of Vancomycin and Piperacillin/tazobactam and Incidence of Acute Kidney Injury at CHI St. Vincent Infirmary

(9-089) Medication Use Evaluation of Dalbavancin at CHI St. Vincent Infirmary

(9-090) Implementation of a Tenecteplase Protocol for Treatment of Acute Ischemic Stroke

(9-091) Effectiveness of Education and Diagnostic Stewardship in Reducing Antibiotics for Urinary Tract Infections

(9-092) Medication Use Evaluation of Injectable Meloxicam at a Community Teaching Hospital

(9-093) Evaluation of Vancomycin Loading Dose Criteria on Incidence of Acute Kidney Injury

(9-094) Optimization of Lipid-Lowering Medications for Secondary Prevention of Cardiovascular Disease in Patients at Family Medicine Clinics

(9-095) Incidence of ICU Delirium When Comparing Benzodiazepine versus Nonbenzodiazepine Sedation in Critically Ill Patients Requiring Ventilation

(9-096) Optimization of the Nasal MRSA PCR Screening Protocol for Early Antibiotic De-escalation Among Patients Presenting with Pneumonia Symptoms

(9-097) Outcomes Associated with Parenteral Lorazepam Medication Shortage Among Inpatient Adult Psychiatric Patients with Agitation

(9-098) Pharmacist Evaluation of Pharmacological and Baseline Risk Factors Associated with the Development of Ileus in a Small to Mid-sized Community Hospital

(9-099) Impact of Glucagon-Like Peptide 1 Receptor Agonist and Sodium Glucose Cotransporter 2 Inhibitor Combination on Glycated Hemoglobin in Outpatient Clinics of an Academic Medical Center

(9-100) Development and Implementation of a PGY2 Population Health Management and Data Analytics Pharmacy Residency Program

(9-101) Assessing the Clinical & Financial Impact of a Clinical Pharmacist-Led Inventory Management in a Large Medical Group

(9-102) Assessing the Impact of Pharmacist’s Presence in the Emergency Department on Administration of Post-Rapid Sequence Intubation Sedation and Analgesia ​

(9-103) Impact of Pharmacist Involvement on Door-To-Needle Time in Patients with Acute Ischemic Stroke upon Arrival to the Emergency Department

(9-104) Efficacy of Nebulized Levalbuterol for the Treatment of Hyperkalemia

(9-105) Long-Acting Intramuscular Cabotegravir and Rilpivirine in Adults for the Maintenance of HIV-1 Suppression and Improvement of Treatment Adherence in County-Based Clinics in Riverside County

(9-106) Assessing the Negative and Positive Predictive Value of MRSA Nares Screen in Skin and Soft Tissue Infections

(9-107) Comparing Toxicities and Outcomes Between Early and Delayed PEGaspargase Administration in ALL Induction Regimens

(9-108) Safety and Efficacy of Cenobamate (XCopri) in Pediatric Patients with Epilepsy

(9-109) Use of Emergent Intramuscular Diphenhydramine, Haloperidol, and Midazolam in Acute Agitation Management

(9-110) A Retrospective Study of the Correlation Between Medications and Falls to Improve Patient Safety at Riverside Community Hospital (RCH)

(9-111) Identifying Barriers Patients with Diabetes Encounter in Receiving Continuous Glucose Monitors According to American Diabetes Association’s Standards When Filling Prescriptions at a Chain Supermarket Pharmacy

(9-112) Impact of a Multi-Modal Order Set in Patients with Severe Traumatic Brain Injury (TBI)

(9-113) Impact of a Hypertonic Saline Protocol in Patients with Hyponatremia

(9-114) Impact of Albumin Stewardship on Albumin Usage in an Organ Transplant Medical Center

(9-115) Impact of a Pharmacist-Led Nirmatrelvir/ritonavir (Paxlovid) Clinic on Medication Related Outcomes and Overall Efficiency for High Risk COVID-19 Patients in an Ambulatory Care Pharmacy Setting

(9-116) Evaluation of Collaborative Strategies Between Ambulatory Care and Community Pharmacy to Improve Pharmacy-Related Star Measures and Blood Pressure for the Medicare Advantage Population

(9-117) Evaluation of the Pharmacist-Led Benzodiazepine Taper Program at Cedars-Sinai Medical Network

(9-118) Immediate Severe Neurologic Toxicity Due to Generic Vigabatrin- a Case of 2 Patients

(9-119) Appropriateness of Empiric Antibiotic Therapy in Trauma Intensive Care Unit Patients with Pneumonia, Urinary Tract Infection, or Bacteremia

(9-120) Medication Use Evaluation of Calcitonin and Pamidronate Use in Hypercalcemia

(9-121) Implementation of a Phenobarbital Order Set for Management of Alcohol Withdrawal Syndrome in the Surgical ICU Population

(9-122) Evaluation of the Efficacy and Safety of Factor Eight Inhibitor Bypassing Activity (FEIBA) Doses in Patients with Apixaban or Rivaroxaban Associated Intracranial Hemorrhage

(9-123) Evaluating Bacterial Resistance and Antibiotic Use of the Antimicrobial Stewardship Program (ASP) at Desert Valley Hospital (DVH) from 2014 to 2021

(9-124) Evaluation of Transition of Thrombolytic Agent from Alteplase to Tenecteplase for Acute Ischemic Stroke Management

(9-125) Evaluation of Intravenous Insulin Management Protocol in Adults with Diabetic Ketoacidosis at Eisenhower Medical Center

(9-126) Evaluation of Safety Outcomes from the Implementation of a Comprehensive Perioperative Medication Management Practice Guideline to Optimize Patient Safety During Surgical Procedures

(9-127) Impact of Pharmacist Dosing Decisions on Effectiveness of Heparin Protocol for Treatment of Venous Thromboembolism in Obese versus Non-obese Patients

(9-128) Implementation of a Payment Model to Encourage Cost Effective Prescribing of VEGF Inhibitors for AMD in an IPA

(9-129) Contribution of Alpha-toxin in Methicillin-Resistant Staphylococcus Aureus Colonization versus Pneumonia and Associated Outcome

(9-130) Efficacy and Safety of Phenobarbital in the Management of Acute Alcohol Withdrawal

(9-131) Sodium Zirconium Cyclosilicate versus Sodium Polystyrene Sulfonate in the Management of Acute Hyperkalemia

(9-132) Impact of Alternative Medication Alerts on Ambulatory Prescribing

(9-133) Assessment of the Substance Use Disorders Clinic for Opioid Use Disorder

(9-134) Incidence of Vancomycin Induced Nephrotoxicity After Implementation of Bayesian Dose-Optimizing Software in a Community Hospital

(9-135) Implementation of a Standardized Inpatient Electronic Health Record Based Oral Chemotherapy Monitoring Process to Improve Pharmacist Workflow

(9-136) Assessing Target Attainment with Pre-Steady State versus Steady State Vancomycin Levels in Obesity with Bayesian Monitoring

(9-137) Quality of Transitions of Care Communication/Documentation for Patients with Non-Cardioembolic Stroke Transferred to Long-Term Acute Care

(9-138) Evaluation of Antithrombotic Management for Patients with Atrial Fibrillation and a History of Coronary Stent Implantation at an Outpatient Electrophysiology Clinic

(9-139) Outcomes of in Person Antimicrobial Stewardship Handshake Rounds at an Academic Medical Center

(9-140) Peace and Quiet in the PENThouse: Medication Use and Dosing Strategies of PENTobarbital Continuous Infusion in Pediatric Patients at a Children's Hospital

(9-141) Baby "Bullets" - Use of 23.4% Sodium Chloride for Neurologic Emergencies and Safely Preventing Delays in Administration at a Children's Hospital

(9-142) Micronutrient Levels in Pediatric Patients with Renal Failure Requiring Continuous Renal Replacement Therapy (CRRT)

(9-143) Supply Shortage Mitigation Strategy: Results from a Single Pediatric Institution Study on Extended Use of ExactaMix 2400 Valve Sets for Parenteral Nutrition Compounding

(9-144) Accuracy of Allergy Documentation: A Retrospective Review of Electronic Health Records (EHRs) at a Pediatric Institution

(9-145) Impact of Palifermin on Outcomes of Hematopoietic Stem Cell Transplant for Pediatric Non-malignant Diseases​

(9-146) Evaluation on the Overuse of Acid Suppressive Therapy in the Hospital Setting

(9-147) Chloride Load and Acute Kidney Injury in Patients with Traumatic Brain Injury Receiving Hypertonic Solutions

(9-148) Assessing Effects of Different Vancomycin Trough Goals on Efficacy and Safety Outcomes in Patients with Therapeutic AUCs Treated for Methicillin-Resistant Staphylococcus Aureus (MRSA) Pneumonia

(9-149) Treatment Outcomes and Cost Analysis of Daptomycin Compared to Vancomycin for Definitive Therapy of Methicillin-Resistance Staphylococcus aureus Bacteremia

(9-150) Evaluating the Efficacy and Safety of a Heparin Infusion Protocol for Patients Transitioning from Direct Oral Anticoagulants (DOAC)

(9-151) Impact of Pharmacist-led Discharge Medication Reconciliation in Reducing Readmission Rates in a Community Hospital

(9-152) Evaluation of Appropriate Cangrelor Dosing and Indication as Bridging in Cardiac Surgery Patients

(9-153) Safety and Efficacy of Heparin Use in Neuro-Critical Patients with a Modified Partial Thromboplastin Time (PTT) Goal

(9-154) Evaluating Impact of Standard versus Non-Standard Dosing of Dexamethasone in Patients with COVID-19

(9-155) Medication Utilization for Managing Agitated Patients Based on Race and Ethnicity

(9-156) Evaluating the Impact of Pharmacists in a Developmental Disabilities Clinic

(9-157) Clinical Outcomes of Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Admitted Heart Failure Patients at a Large Academic Medical Center

(9-158) Effects of Therapeutic Hypothermia on Heparin Treatment Post Cardiac Arrest

(9-159) Effects of Early Adjunctive Enteral Sedation on Time to Spontaneous Breathing Trials and Intravenous Sedative Agent Requirements in Mechanically Ventilated Acute Respiratory Distress Syndrome Patients

(9-160) Evaluation of Efficacy and Safety of Combination Haloperidol, Lorazepam, and Diphenhydramine versus Combination Haloperidol and Diphenhydramine in Acute Agitation

(9-161) Impact of a Pharmacist-driven Inhaler Clinic on Outcomes Related to COPD in a Federally Qualified Health Center

(9-162) Evaluation of the Incidence of Intracerebral Hemorrhage in Elderly Patients 75 Years or Older on Direct Oral Anticoagulants

(9-163) Vancomycin and Doxycycline Usage in Hospitalized Adult Patients with Uncomplicated Cellulitis

(9-164) Implementing a Machine Learning Clinical Decision Support Tool to Detect and Treat Non-Valvular Atrial Fibrillation in the Emergency Department

(9-165) Impact of Early Initiation of Daptomycin Plus Ceftaroline versus Standard of Care for Treatment of Methicillin Resistant Staphylococcus Aureus Bacteremia on Hospital Length of Stay

(9-166) Effectiveness of 4.5 Mg/kg vs. Standard 6 Mg/kg Induction Dose of Rabbit Anti-Thymocyte Globulin (rATG) at Preventing Rejection in Kidney Transplant Recipients

(9-167) Use of a Novel Pictorial Medication Guide to Educate Hospitalized Patients on the Purpose and Side Effects of Their Medications

(9-168) Implementation of a Multidisciplinary Controlled Substance Diversion Prevention Program at an Academic Health System

(9-169) Implementation of Pharmacy Program and Clinic to Provide Consultation on Pharmacogenetic Testing and Results

(9-170) Implementation and Evaluation of a Non-Alcoholic Fatty Liver Disease (NAFLD) Clinical Pharmacy Service Within a Hepatology Clinic

(9-171) Therapeutic Phenytoin Monitoring for Early Seizure Prophylaxis in Patients with Traumatic Brain Injury (TBI)

(9-172) Medication Reconciliation and Transitions of Care Pharmacist Interventions in Geriatric Consult Patients

(9-173) Can Other Local Anesthetics Be Administered Within 96 Hours Following Liposomal Bupivacaine? Defining a Safety Profile for Liposomal Bupivacaine (Exparel) Use at Stanford Health Care

(9-174) Basiliximab versus No Induction Therapy: Incidence of Lung Transplant Rejection and Chronic Lung Allograft Dysfunction

(9-175) Impact in Converting Aspergillus Prophylaxis from Itraconazole to Posaconazole in Heart Transplant

(9-176) Actual Body Weight versus Ideal Body Weight for Antithymocyte Globulin Induction Dosing and Its Impact on Heart Transplant Rejection

(9-177) Is Everything Ok? Incidence of Hyperkalemia After Converting to Daily Trimethoprim-Sulfamethoxazole in Place of Monday, Wednesday, and Friday Dosing in Lung and Heart-Lung Transplant

(9-178) Evaluation of a Batch Production Protocol of Intravenous Ketamine for Acute Pain in the Emergency Department

(9-179) Remdesivir Medication Utilization Evaluation at a Free-standing Childrens Hospital

(9-180) Retrospective Study Evaluating Clostridioides difficile Reinfection Rates Between Fidaxomicin and Vancomycin

(9-181) Would Improving the Medication Delivery Process Reduce Missing Medications and Delay in Patient Care at an Inpatient Hospital?

(9-182) Efficacy of Probiotics for Necrotizing Enterocolitis Prophylaxis in the Neonatal Intensive Care Unit

(9-183) The State of Therapy Specific Outcomes Across Health-System Specialty Pharmacies

(9-184) Evaluation of Institution-Implemented Fixed Dose 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Intracranial Hemorrhages

(9-185) Cost-benefit Analysis of a Clinical Discharge Clinic in a Community Pharmacy

(9-186) Impact of Paralytic Choice on Post Intubation Analgesia and Sedation in the Emergency Department

(9-187) Evaluation of Liver Function Improvement with N-Acetylcysteine for Acetaminophen Toxicity

(9-188) Impact of Student Pharmacist Intervention on Readmission Rates in Patients with Heart Failure with Reduced Ejection Fraction in the Internal Medicine Setting

(9-189) Change of Hemoglobin A1c in Low-income Hispanic Populations Before and After Sodium-glucose Cotransporter 2 Inhibitors (SGLT2) Initiation

(9-190) Reliability of Reported Self-Monitoring of Blood Glucose (SMBG) Values Compared to Hemoglobin A1c Level and Pharmacists' Interventions in Patients with Type 2 Diabetes

(9-191) The Development and Implementation of a Retrospective Psychotropic Stewardship Protocol in the Primary Care Setting

(9-192) Community Specific Perceptions of Initiating Pre-exposure Prophylaxis in a Pharmacy in Young Men of Color Who Have Sex with Men in San Francisco Bay Area

(9-193) Insulin Management of Steroid-Induced Hyperglycemia in the Hospital Setting and the Prevention of Hypoglycemia

(9-194) A Retrospective Review of Intravenous Albumin Use Adherence to Strict Clinical Guidelines

(9-195) Patient Perceptions and Attitudes of Pharmacist Delivered Patient Care Services

(9-196) Assessment of the Pharmacy Technician Workforce Retention and Desired Opportunities for Growth

(9-197) Evaluating the Effect of Provider Education, Feedback, and Workflow Modification on the Frequency of Prescribed Antibiotics for Urinary Tract Infections in the Outpatient Setting

(9-198) Evaluating the Effect of Implementing Computerized Provider Order Entry Lab Monitoring Alerts for Narrow Therapeutic Index Drugs

(9-199) Evaluating the Effect of a Pharmacist-Led Education on Allergy Documentation and Reporting in a Community Hospital Setting

(9-200) Implementation of Phenobarbital Loading Dose Rounding for Alcohol Withdrawal to Improve Time to Administration in the Emergency Department

(9-201) Evaluation of a System-wide Diabetic Ketoacidosis Treatment Order Set

(9-202) Facilitating Early Hospital Discharge and Clinical Success Using Oritavancin in a Community-Based Health System

(9-203) Nitroprusside Titration Practices and Safety

(9-204) Evaluation of a Neuromuscular Blocking Agent Order Set in Achieving and Maintaining Adequate Sedation

(9-205) Pharmacist Presence in the Emergency Department and the Impact on Capturing Outpatient Discharge Prescriptions

(9-206) Intrathecal Nicardipine for the Treatment of Super-refractory Cerebral Vasospasms Following Intracranial Infection in a Pediatric Patient

(9-207) Serotonin Syndrome in an Adolescent After Recent Discontinuation of Cyproheptadine and a Single Accidental Dose of Escitalopram

(9-208) Evaluation of Ketorolac Ceiling Dose Effects in Pediatric Patients in the Emergency Department

(9-209) Letermovir for Cytomegalovirus Prophylaxis in Pediatric Hematopoietic Stem Cell Transplantation

(9-210) Diuretic Exposure and Correlation with Oxygen Requirements in Infants Born at Less Than 29 Weeks Gestation

(9-211) Impact of Pharmacogenomic Testing on Psychotropic Medication Prescribing in an Ambulatory Child and Adolescent Psychiatry Clinic and a Developmental Pediatrics Clinic

(9-212) Clinical Characteristics of Juvenile Idiopathic Arthritis Patients Who Undergo Adalimumab Drug Concentration Testing and Anti-Drug Antibody Assessment

(9-213) Dexmedetomidine to Clonidine: Weaning Sedation in the Pediatric Population

(9-214) Central Lines, Aseptic Batching Services, and Infection Rates: A Retrospective Review of Central Line-Associated Bloodstream Infection (CLABSI) Rates in a Neonatal Intensive Care Unit

(9-215) Ketamine in the Pediatric Emergency Department: Tracking Acute Medical Intervention Sedations, a Non-Standardized Dosing Evaluation

(9-216) The Use of Alternatives to Opioids (ALTOs) and the Impact on Patient's Pain Scores and Pain-Related Quality Measures

(9-217) Inpatient Mortality Comparison Between Succinylcholine and Rocuronium in Patients Who Present to the Emergency Department with Traumatic Brain Injury

(9-218) Assessing the Need for Vascular Access: Analyzing Clinical Indications Requiring Central Access and Corresponding Effects on the Rates of Central Line Associated Bloodstream Infections (CLABSIs)

(9-219) Methadone-Induced Torsades De Pointes in the Setting of Opioid Withdrawal

(9-220) Evaluation of I.V. Room Batching Process and Implementation of Interventions to Improve Efficiencies in an Institutional Setting

(9-221) Evaluation of Nephrotoxicity in Liver Transplant Recipients Receiving Vancomycin and Piperacillin-Tazobactam for Post-Operative Prophylaxis

(9-222) Evaluation of Enoxaparin Given by Subcutaneous (SC) vs. Intravenous (IV) Routes in Achieving Target Anti-Xa Levels in Pediatric Patients

(9-223) Safety Evaluation of Continuous Infusion Lidocaine for Pain on Internal Medicine Floors

(9-224) “A Retrospective Analysis of Vancomycin AUC vs Trough-Based Dosing at Reducing the Incidence of AKI”

(9-225) Treatment of Alcohol Withdrawal Syndromes: Minnesota Detoxification Scale (MINDS) Protocol versus Clinical Institute Withdrawal Assessment (CIWA) Protocol and Rates of Oversedation

(9-226) Comparison of the Effectiveness, Safety, and Compliance to Inpatient Pharmacy Warfarin Protocols

(9-227) Impact of Peripheral versus Central Vasopressors in Septic Patients

(9-228) Characterization of Hypoglycemia Risk in the Inpatient Setting: A Retrospective Chart Review

(9-229) Retrospective Comparison and Cost Analysis of Dinoprostone to Oral and Vaginal Misoprostol for Cervical Ripening on the Labor and Delivery Unit

(9-230) Benzodiazepine Dosing in Status Epilepticus Patients in the Emergency Department

(9-231) Evaluation of Antimicrobial Prescribing Patterns for Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Infections in a Health System

(9-232) Optimizing Value Capture Through an Automated Contract Pricing Surveillance Process

(9-233) Cost-effectiveness Analysis of Single Pill Regimen Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Raltegravir and Emtricitabine/Tenofovir Alafenamide in a Community Teaching Hospital

(9-234) The Clinical Impact of a Pharmacist-Driven Vancomycin Outpatient Parenteral Antimicrobial Therapy (V-OPAT) Service

(9-235) Evaluation of Heart Failure with Preserved Ejection Fraction Prescribing Practices Across a Five-Hospital Health System

(9-236) Establishing the Framework for a High-Cost Drug Stewardship Program Across a Five-Hospital Health System

(9-237) Evaluating Use of Free and Total Phenytoin Levels to Establish Guidance for Therapeutic Drug Monitoring at a Large Academic Health System

(9-238) Initiating a Long-acting Injectable Antipsychotic Clinic Within the Community Pharmacy Setting to Increase Access to Therapy

(9-239) Evaluating the Impact of Phenobarbital Boluses in Patients Experiencing Severe Alcohol Withdrawal Across a Health System

(9-240) Efficacy of Secondary Oral Vancomycin Prophylaxis in a High-Risk Patient Population Receiving Systemic Antibiotics

(9-241) Safety of High-Dose Subcutaneous Heparin for Venous Thromboembolism Prophylaxis in Obese Inpatients

(9-242) Do Missed Doses of Pharmacologic Venous Thromboembolism (VTE) Prophylaxis Increase VTE Events in Trauma Patients with Pelvis, Acetabulum, and Femur Fractures?

(9-243) Euglycemic Diabetic Ketoacidosis and Time to Anion Gap Closure – Comparison of Outcomes to a Hyperglycemic Diabetic Ketoacidosis Cohort

(9-244) Management of Sexually Transmitted Infections in the Emergency Department: Assessment of Common Practice in a Healthcare System

(9-245) Evaluation of Timing of Surgical Prophylaxis Antibiotics and Rates of Surgical Site Infections

(9-246) Beta Get It Right! Impact of Multidisciplinary Education on Allergy Documentation and Beta-Lactam Deprescribing

(9-247) P2Y12 Inhibitor Use Associated with Coronary Stenting in Acute Coronary Syndromes

(9-248) Evaluation of the Management of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction Across a Five-Hospital Health System

(9-249) Identification of Inpatient Hypoglycemia Risk Factors in a Five Hospital Health System

(9-250) Effect of Esketamine on PHQ-9 Score, Emergency Department Visits, and Hospitalizations of Patients with Treatment Resistant Depression in a Community Hospital Setting

(9-251) Observational Comparison of Phenobarbital and Lorazepam for Acute Alcohol Withdrawal Management in the Intensive Care Unit

(9-252) Evaluation of a New Heparin Protocol Utilizing Anti-Xa Levels for Anticoagulation Monitoring at a Seven Hospital Healthcare System

(9-253) Impact of Pharmacy Intervention on HCAHPS Scores and Readmission Rates in a Community Hospital

(9-254) Effect of Overlapping Insulin Glargine Administration in Decreasing Incidence of Hyperglycemia After Discontinuation of Intravenous Insulin Infusion

(9-255) Impact of a Nurse-Driven Diuretic Protocol on Hospital Length of Stay in Patients with Acute Heart Failure Exacerbations

(9-256) Impact of Implementing Education and Electronic Medical Record Tools on Pneumococcal Vaccination Rates in a Primary Care Clinic

(9-257) Evaluating Initiation and Discontinuation of Stress Ulcer Prophylaxis in the Critical Care Setting and Beyond

(9-258) Impact of Sodium Bicarbonate on Mortality in Cardiac Arrest Matched for Initial Presenting Rhythm

(9-259) Evaluation of Emergency Department Length of Stay Following Acute Pain Management in the Pre-Hospital, Emergency Medical Services Setting

(9-260) Establishing and Evaluating an Advanced Preparation Program in an Adult Ambulatory Infusion Center

(9-261) Optimizing the Smart Pump Drug Library to Decrease Override Rates at an Academic Teaching Hospital

(9-262) Clinical Outcomes of Anticoagulation Clinic Patients When Run by a Nurse Practitioner versus a Pharmacist

(9-263) Comparison of Tenecteplase vs. Alteplase Door-to-Needle Time in Acute Ischemic Stroke

(9-264) Assessing Rates of Adverse Effects Between Patients with or Without Morbid Obesity Receiving Propofol or Dexmedetomidine in the Intensive Care Unit

(9-265) Evaluation of the Impact of Ambulatory Care Pharmacists Within Multidisciplinary Rheumatology Clinics

(9-266) Expanding Pharmacist Collaborative Practice Agreements Across Multiple States Within a Large Academic Health System

(9-267) Evaluating Non-formulary Medication Processes to Enhance Inventory Management

(9-268) Opioid Overdose Risk Assessment of Outpatient Behavioral Health Patients to Estimate Benefits of On-Site Naloxone Storage

(9-269) Evaluation of Inspiratory Flow Rate (IFR) for Patients with Chronic Pulmonary Diseases

(9-270) Optimization of an Integrated Pharmacist Collaborative Care Model in Specialty Disease State Clinics

(9-271) Real World Review of Infliximab Biosimilars at a Large Academic Health System

(9-272) Evaluation of an Ambulatory Opioid Stewardship Dashboard: Ensuring Robust Measures

(9-273) Evaluation of Clotting Factor Product Utilization in a Large Health System

(9-274) Intravenous Hypertensive Medication Use in Medicine and Surgical Care Areas Across a Five-Hospital Health System

(9-275) Evaluation of Potassium and Magnesium Replacement Protocols in a Five-hospital Health System

(9-276) Consistent Evaluation of Medications Not Used and Formulary Removal Across a Large Academic Medical Center

(9-277) Allergy Optimization: Characterization and Standardization of the “Other” Allergen Field

(9-278) Evaluating Valproic Acid Drug Monitoring to Establish Guidance for Therapeutic Drug Monitoring at a Large Academic Health System

(9-279) Implementation of Rapid Infliximab Infusions in a Large Academic Health System

(9-280) Evaluation of Pegfilgrastim Biosimilar Rule-Based Ordering Technology in Alignment with Institution Formulary and Payer Preference

(9-281) Assessing Health-System Ordering Practices for as Needed Pain Management in Post-Operative Inpatient Adults

(9-282) Evaluation of Therapeutic Duplication Reduction Strategies Throughout Yale New Haven Health System

(9-283) Effect of Antiproliferative Dose on Clinical Outcomes in Adult Kidney Transplant Recipients Maintained on Belatacept

(9-284) Sirolimus in Heart Transplant Recipients – Review of Sirolimus Dosing Strategies and Optimization of Conversions

(9-285) Evaluating the Documentation Process of High Risk Medications During Bedside Procedures

(9-286) Melatonin Prescribing Patterns in Hospitalized Pediatric Patients

(9-287) Evaluation of Adherence to a Clinical Pathway for Uncomplicated Community Acquired Pneumonia at a Pediatric Hospital

(9-288) Evaluation of VTE Prophylaxis Usage Post-Intracranial Hemorrhage in the Rehabilitation Setting

(9-289) Acute Ischemic Stroke Outcomes with Alteplase vs a Pharmacist-Developed Tenecteplase Dose-Rounding Approach

(9-290) Septic Shock Severity on Vasopressin Response

(9-291) Retrospective Analysis of Empagliflozin Use for the Treatment of Acute Heart Failure Exacerbations

(9-292) Evaluation of Proper Administration of Heparin at HCA Florida Largo Hospital

(9-293) Evaluation of Time to Optimal Therapy in Patients with Escherichia coli Bacteremia Utilizing BioFire BCID versus BCID2 PCR Panel Results

(9-294) Evaluation of the Impact of Diagnostic Stewardship Strategies on Antibiotic Prescribing for Asymptomatic Bacteriuria

(9-295) Evaluation of Parental Nutrition Additives and Micronutrients Across a Community Health Care System

(9-296) Saccharomyces Boulardii and the Incidence of Clostridioides Difficile in Patients Receiving Chemotherapy

(9-297) Efficacy of Opioid-Induced Constipation Treatment Modalities at an Academic Hospital

(9-298) Post-operative Treatment with Once-daily Ceftriaxone Plus Metronidazole versus Anti-Pseudomonal Antibiotics in Pediatric Patients with Perforated Appendicitis

(9-299) Evaluation of Health System Prescribing Pattern of Prophylactic Antiepileptic Drugs in Neurocritical Care Adults

(9-300) Determining Pharmacists’ Role in Providing Healthcare in Medically Underserved Communities in Florida. a Collaboration Between Physicians and Pharmacists

(9-301) Impact of Parenteral Bridging on Bleeding Outcomes in Patients Who Require Direct Oral Anticoagulant Interruption for an Elective Surgical Procedure

(9-302) Case Report: COVID-19 Induced Acute Pericarditis with Bloody Pericardial Effusion in Young Man

(9-303) Intravenous to Oral Medication Conversions: Identifying Opportunities

(9-304) Evaluation of Dalbavancin Utilization and Missed Opportunities in Patients with Uncomplicated Acute Bacterial Skin and Skin-Structure Infections

(9-305) Analysis of Glycemic Management Outcomes in Rural Acute Care Community Hospital

(9-306) Comparison of Once Daily versus Twice Daily Insulin Glargine Dosing for Management in Critically Ill Patients

(9-307) Interventions Performed by Emergency Medicine Pharmacists in an Academic Emergency Department

(9-308) Medication Use Evaluation: Magnesium Infusion Administration Rates

(9-309) Evaluation of the Effectiveness of the AdventHealth for Children Vancomycin Dosing Protocol to Achieve Therapeutic Vancomycin Trough Concentration in Hospitalized Pediatric Patients

(9-310) Evaluation of Compliance to Institutional Criteria for Use of Meropenem in Pediatric Patients

(9-311) Evaluation of Standardization of a Pharmacy Led Medication History Workflow Across a Healthcare System

(9-312) Evaluation of Epoetin Dosing Strategies in Acutely Ill Hospitalized Patients

(9-313) Fluid Resuscitation Strategies in Patients Receiving Extracorporeal Membrane Oxygenation

(9-314) Characterization of Inhaled Antimicrobials in Critically Ill Patients Across a Large Healthcare System

(9-315) Adherence to Internal Fidaxomicin Criteria for Use in a Multi-Center Health System

(9-316) Evaluation of Prophylactic Enoxaparin Use in Extreme Body Weights: A Retrospective Review

(9-317) Evaluation of the Transition Process from Intravenous to Subcutaneous Insulin in Non-Critically Ill Patients

(9-318) Effect of a Pharmacist-Run Clinic on Time to Disease State Management in Patients Provided with Necessary Home Monitoring Tools and Regular Follow-Up

(9-319) Impact of Pharmacy-Driven Medication Reconciliation in the Emergency Department

(9-320) Impact of Pharmacist Response to Rapid Diagnostics of Gram Positive and Gram Negative Blood Culture Identification

(9-321) Assessing the Incidence of Infusion-Related Reactions in a Pediatric Outpatient Infusion Center and Their Relation to the Administration of Pre-Treatment Medications

(9-322) Impact of a Pharmacy-driven Culture Callback Protocol on Antimicrobial Therapy Optimization in the Emergency Department

(9-323) Infectious Diseases Pharmacist Led Culturing Stewardship Team Impact on Urinalysis and Urine Cultures in the Emergency Department of a Community Teaching Hospital

(9-324) Cefoxitin versus Cefazolin Plus Metronidazole for Perioperative Prophylaxis in Colorectal Surgery

(9-325) Retrospective Analysis of Droperidol Usage Practices in the Acute Care Setting

(9-326) Retrospective Analysis of Purge Solutions for Left Ventricular Assist Devices in Patients with Cardiogenic Shock

(9-327) Comparison of Pre- versus Post-implementation of a Pharmacist-driven Culture Call-back Program

(9-328) Retrospective Analysis of Rabies Immunoglobulin Products and Administration Practices for Rabies Post-Exposure Prophylaxis

(9-329) Comparison of the Safety and Efficacy of IV Push versus IV Piggyback Antiepileptics

(9-330) Assessing Adherence to Rifaximin Drug Use Criteria in Patients with Hepatic Encephalopathy in a Community Hospital Setting

(9-331) Intraspinal Clonidine Containing Regimen Compared to Intraspinal Fentanyl Containing Regimen on Post-Operative Pain Management Outcomes in Orthopedic Surgeries in a Community Hospital

(9-332) Evaluation of an Interdisciplinary Lipid Management Program for Treating Patients with Severe Lipid Disorders

(9-333) Avoiding Clinical Inertia: Comparing Time to Intensification of Glucagon-like peptide-1 (GLP-1) Receptor Agonists in Patients with Type 2 Diabetes Mellitus Among Clinical Pharmacists versus Providers

(9-334) Evaluation of Early versus Late Midodrine Therapy in Patients with Persistent Hypotension Requiring Intravenous Vasopressors

(9-335) Impact of Source-Based Antibiotic Order Sets for Sepsis Within a Community Hospital

(9-336) Evaluating the Incidence of Post-Partum Hemorrhage After Oxytocin Process Standardization

(9-337) Impact of Midodrine on Optimization of Beta-blocker Therapy in Heart Failure with Reduced Ejection Fraction (HFrEF) Patients

(9-338) Evaluation of a 3% Hypertonic Saline Protocol for the Management of Hyponatremia

(9-339) Implementation of Critical Care Clinical Pharmacy Services in an Electronic Intensive Care Unit (eICU)

(9-340) Assessment of Fixed-schedule versus Symptom-triggered Benzodiazepine Prescribing Patterns for Prevention of Alcohol Withdrawal Syndrome in ICU Patients

(9-341) Use of Diphenhydramine for Patients 65 Years of Age and Older for Inpatient Management of Insomnia

(9-342) Effects of Liposomal Bupivacaine vs. Conventional Bupivacaine, Ketorolac and Ketamine on Opioid Use for Post-Surgical Pain Control Following Shoulder Arthroplasty, a Retrospective Chart Review

(9-343) Impact of an In-Office Medication Dispensing Program on Hospital Admissions and Medication Adherence

(9-344) Midodrine Usage to Accelerate IV Vasopressor Discontinuation in Critically Ill Patients with Septic Shock

(9-345) Comparison of MRSA Nares PCR versus Microbial Culture Guided Vancomycin De-escalation in Patients Hospitalized for Bacterial Pneumonia

(9-346) Liposomal Bupivacaine Compared to Bupivacaine for Postoperative Analgesia Following Spine Surgery

(9-348) Evaluation of Venous Thromboembolism Prophylaxis Protocol in Adult Patients with Traumatic Brain Injury, Spinal Cord Injury, and Intracranial Hemorrhage

(9-349) Comparison of Adherence Rates of Antiretroviral Therapy Filled at an Integrated Health-System Pharmacy vs. External Pharmacies

(9-350) Optimization of Electronic Health Record Frequency Practice Standards to Decrease Delays in Antibiotic Time to First Dose

(9-351) Financial Outcomes of Switching from Dipeptidyl Peptidase-4 Inhibitors to Sodium-Glucose Cotransporter 2 Inhibitors While on Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease

(9-352) PD-1 Inhibitors and Thyroid Dysfunction: A Retrospective Review of Monitoring and Management

(9-353) Cutting Back Time to Appropriate Antimicrobial Therapy with PCR-Based Blood Culture Identification Panel

(9-354) Evaluation of Empiric Vancomycin Dosing in Septic Patients Presenting to the Emergency Department

(9-355) Impact of Posaconazole Prophylaxis Protocol on Invasive Fungal Infections in Heart Transplant Recipients

(9-356) Impact of Prophylactic Use of Levetiracetam on Seizure Incidence After Spontaneous Intracerebral Hemorrhage

(9-357) Efficacy of 3 Mg vs 4.5 Mg of Rasburicase on Uric Acid Reduction in Tumor Lysis Syndrome

(9-358) Cost-effectiveness of Periarticular Ropivacaine, Epinephrine, Clonidine, and Ketorolac versus Liposomal Bupivacaine in Unilateral Total Knee Arthroplasty Patients: A Retrospective, Matched-cohort Analysis

(9-359) Dexmedetomidine Use for Delirium in Neurocritical Care Patients

(9-360) To Evaluate the Safe and Effective Use of Pentobarbital for Super-Refractory Status Epilepticus

(9-361) Effectiveness of Pharmacist-Driven HF Discharge Checklist

(9-362) Efficacy of Darbepoetin Alfa Compared to Epoetin Alfa Utilization in Anemia of Prematurity

(9-363) Assessing the Efficacy of Indomethacin, Ibuprofen, and Acetaminophen in Patent Ductus Arteriosus Closure in Neonates at a Level III Neonatal Intensive Care Unit

(9-364) Evaluation of Sugammadex Use in Adult Patients Within a Community Teaching Hospital

(9-365) Safety and Effectiveness of Transition from Intravenous to Subcutaneous Insulin on Post-Operative Day One in Patients Undergoing Coronary Artery Bypass Graft (CABG)

(9-366) Impact of Tamsulosin on Successful Foley Catheter Discontinuation in Females

(9-367) Impact of Meloxicam/bupivacaine on Patients That Underwent Total Knee Arthroplasty

(9-368) Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Chart Review on Appropriate Discharge Regimens

(9-369) Evaluating the Impact of Pharmacist-driven Intervention in Patients Receiving Heparin Infusions

(9-370) Evaluation of Supplemental Benzodiazepine Administration for Patients on CIWA

(9-371) Protective Effects of Melatonin on Vancomycin-Induced Nephrotoxicity in Hospitalized Patients

(9-372) Safe and Effective Use of Tenecteplase for Acute Ischemic Stroke

(9-373) Identifying and Mitigating Medication Related Risk of Falls for Patients Admitted in the Hospital

(9-374) Outcomes of an Electronic Intensive Care Unit Pharmacist on the Management of Diabetic Ketoacidosis

(9-375) Pharmacist-Led Glucose Management for Non-Critically Ill Hospitalized Patients

(9-376) Improving a Pharmacist-Driven Penicillin Skin Testing Program for Hospitalized Patients Using the Institute for Healthcare Improvement (IHI) Model for Improvement

(9-377) The Impact of Pharmacy-led Medication Reviews and Transitional Care Services on 30-days Readmission Rates in a Teaching Hospital

(9-378) The Role of a Transitions-of-Care Pharmacist in a Collaborative, Interdisciplinary Team

(9-379) Comparison of Two Admission Intravenous Fluids in a Neonatal Intensive Care Unit

(9-380) Evaluation of Methotrexate Clearance in Pediatric Patients with Osteosarcoma

(9-381) Evaluation of Dosing and Monitoring Practices for Treatment-Dose Enoxaparin in Pediatric Patients

(9-382) Evaluation of Discharge Medications for Patients with an A1c > 10% During Admission

(9-383) Valproic Acid Use in Critically Ill Trauma Patients

(9-384) Fosfomycin Use in the Emergency Department

(9-385) Lorazepam Use for Status Epilepticus in the Emergency Department

(9-386) An Evaluation for Tacrolimus Monitoring at a Non-transplant Community Hospital

(9-387) Restoration of Function to Clotted Venous Access Devises Using Alteplase 2 Mg

(9-388) Pegfilgrastim Utilization and Assessment of Cost-saving Opportunities at an Outpatient Cancer Center

(9-389) Intraoperative Methadone’s Impact on Post-Cardiothoracic Surgery Opioid Consumption

(9-390) Assessment of 22-Hour Gentamicin Levels in Neonatal Intensive Care Unit Patients Post-Maternal Gentamicin Administration

(9-391) Evaluation of Treatment of Community Acquired Pneumonia at a Community Based Teaching Hospital

(9-392) Medication Use Evaluation of Intravenous Iron Sucrose

(9-393) Evaluation of the Safety Profile and Cost Impact of Fixed-dose Subcutaneous Pertuzumab/trastuzumab/hyaluronidase-zzxf in HER2-positive Breast Cancer

(9-394) Safety Evaluation of Rituximab Biosimilars in a Multisite Cancer Center

(9-395) Retrospective Review to Identify Risk Factors for AKI in Non-Cardiac, Postsurgical Patients

(9-396) Comparison of a Weight-based Heparin Deep Vein Thrombosis and Pulmonary Embolism Treatment Protocol to a Cardiac Treatment Protocol in Achieving Therapeutic Activated Partial Thromboplastin Time

(9-397) Incidence of Acute Kidney Injury in Patients Receiving Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Cefepime

(9-398) Impact of a Pharmacist-led Transitions of Care Service on Duration of Antibiotic Therapy for Patients Receiving Treatment for Pneumonia or Urinary Tract Infection

(9-399) Implementation of Penicillin De-labeling in a Community Hospital Setting

(9-400) Economic Impact of a Pharmacist-Led Care Gap Driven Program Integrated Within a Large Healthcare System’s Primary Care Clinics Targeting a Value-Based Population

(9-401) Assessing Neurological Outcomes in Patients with Extremely Elevated Systolic Blood Pressure and Intracerebral Hemorrhage After Acute Blood Pressure Reduction

(9-402) Nitric Oxide Inhibition in Refractory Septic Shock

(9-403) Comparing Efficacy Between Rituximab Biosimiliars and Rituximab Reference Product in Treating Aggressive B-cell Lymphomas: Non-Interiority, Retrospective Cohort Study

(9-404) Evaluating a Four Drug Regimen with Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Multiple Myeloma Patients Receiving High Dose Melphalan

(9-405) Assessment of Clinical Pharmacist Interventions Through Retrospective Long-Acting Opioid Therapy Review to Optimize Pain Management

(9-406) Assess the Impact of a Pharmacist-led Value-based Diabetes Management Program Integrated Within a Large Healthcare System’s Primary Care Practice

(9-407) Retrospective Evaluation of Perioperative Use of Intravenous Levothyroxine in Adult Heart Transplant Recipients

(9-408) Evaluation of Outcomes After Implementation of a Hyponatremia Management Order Set in an Acute Care Facility

(9-409) Outcomes of Platinum Related Desensitization Within an Inpatient Setting

(9-410) Evaluation of Methotrexate Toxicity Management Practices for the Development of a Pharmacist Driven Leucovorin Dosing Protocol Within a Community Hospital

(9-411) Real-World Incidence of Cardiac Adverse Effects with Ibrutinib, Acalabrutinib, and Zanubrutinib at a Community Cancer Center

(9-412) Clinical Outcomes of Treatment Sequencing in AR-V7 Negative Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients

(9-413) Impact of a Pharmacist-Driven Transitions of Care Program Through Medication Reconciliation and Discharge Counseling Services

(9-414) Parenteral Antipsychotic Use Within a Community Hospital Health System

(9-415) Carbapenem Utilization Within a Community Health System

(9-416) Evaluations of Clinical and Bacteriological Outcomes of Vancomycin AUC/MIC Monitoring in Pediatric Patients Treated for Organisms Other Than Methicillin-Resistant Staphylococcus aureus (MRSA)

(9-417) Evaluation of Octreotide Safety and Efficacy for Chylothorax in Pediatric Patients

(9-418) Incidence of Behavioral Side Effects with Brivaracetam in Children and Adolescents

(9-419) Assessing the Gaps in Knowledge in Recently Diagnosed Type 2 Diabetic Patients. a Cross Sectional Study

(9-420) Evaluation of Pharmacist Involvement in Multidisciplinary Home Visits in a Primary Care Based Accountable Care Organization

(9-421) Assessing Perceived Confidence and Competence of Student Pharmacists in a Virtual Medication Adherence Training Program

(9-422) Implementation of a Beta-Lactam Allergy De-labeling Guideline in a Pediatric Community Hospital

(9-424) Safety and Effectiveness of Ceftazidime/Avibactam in Older Adults: A Retrospective Observational Study

(9-425) Impact of a Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Screening Protocol on Vancomycin Utilization at a Community Teaching Hospital

(9-426) Impact of Pharmacist-Driven-Transitions of Care (TOC) Program on 30-Day Readmission Rate in a Community Teaching Hospital

(9-427) Justification of a Hemostatic and Antithrombotic Stewardship Program at a Large Community Hospital

(9-428) Impact of a Calcium Replacement Protocol in Trauma Patients Receiving Massive Transfusion

(9-429) Impact of Early Initiation of Venous Thromboembolism Prophylaxis in Critically Ill Patients with Aneurysmal Subarachnoid Hemorrhage

(9-430) Assessment of the Management and Clinical Outcomes of Patients with Staphylococcus Aureus Bacteremia at a Large Community Teaching Hospital

(9-431) Pharmacist Driven Evaluation and Development of a Multimodal Analgesia Protocol in Orthopedic Trauma Patients

(9-432) Pharmacy Technician Workload Characterization in the Inpatient Setting

(9-433) Evaluation of SGLT2 Inhibitors at an Outpatient Cardiology Clinic

(9-434) Pharmacist Impact in Preventing Emergency Department Visits and Hospital Readmissions for Heart Failure Patients in a Transitions of Care Setting

(9-435) Enoxaparin vs Unfractionated Heparin for Venous Thromboembolism (VTE) Prophylaxis in Trauma Patients

(9-436) Clinical Outcomes of Therapeutic Vancomycin Monitoring: Comparing Area Under the Curve- to Trough-Guided Dosing

(9-437) A Survey Study Comparing Prior Patient Naloxone Knowledge and Pharmacist-Led Counseling to Naloxone Purchases and Reasons for Naloxone Refusal

(9-438) Evaluation of Bloodstream Infection Incidence for Hospitalized Patients Requiring Total Parenteral Nutrition (TPN) Compared to Patients with Central Venous Catheters in Place Receiving Oral/enteral Diet

(9-439) Clinical Review of Liposomal Bupivacaine on Opioid Use and Length of Stay in Laparoscopic Colorectal Surgeries

(9-440) Evaluating the Incidence of Hypoglycemic Events in Hospitalized Patients on Subcutaneous Insulin and Reviewing the Appropriateness of Hypoglycemic Management Based on a Community Hospital Protocol

(9-441) Evaluation of the Management of Acute Bacterial Skin and Skin Structure Infection at a Community Hospital

(9-442) A Retrospective Study of Patients ≥ 65 Years Old with Type 2 Diabetes Mellitus and Characteristics Associated with Sulfonylurea Utilization

(9-443) Analysis of Billing Processes for Pharmacist Prescribed Hormonal Contraception

(9-444) You Can’t Spell HealTHCare Without THC: Utilization of Treatment Strategies for Cannabis Hyperemesis Syndrome in Pediatric Patients at Children’s Healthcare of Atlanta

(9-445) Utilization of Eculizumab in Pediatric Patients with TA-TMA, DHTR and Other Anemias at Children’s Healthcare of Atlanta

(9-446) Safety and Efficacy of Early Antibiotic Discontinuation in Febrile Neutropenic Patients

(9-447) Safety and Efficacy of Early Antibiotic Discontinuation in Febrile Neutropenic Patients

(9-448) Determining the Rate of Acute Kidney Injury in Patients Receiving Zoledronic Acid for Hypercalcemia of Malignancy

(9-449) Evaluating the Use of N-acetylcysteine for Non-acetaminophen Induced Acute Liver Failure

(9-450) Efficacy and Safety of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with a Left Ventricular Assist Device

(9-451) Comparison of High-risk Discrepancies in Medication Histories Taken by Pharmacy versus Non-pharmacy Personnel

(9-452) Nephrotoxic Risk Associated with Combination Therapy of Vancomycin and Piperacillin-Tazobactam in Critically Ill Patients with Chronic Kidney Disease

(9-453) A Comparison of Tocilizumab or Baricitinib for Hospitalized Patients with Severe COVID-19

(9-454) Long-term Dalbavancin for Suppression of Gram-positive Chronic Left Ventricular Assist Device Infections

(9-455) Characteristics Associated with Inpatient Opioid-Related Adverse Drug Events at an Academic Medical Center

(9-456) Neurologic Complications Early After Liver Transplant

(9-457) Effect of $0 Copayment on Medicare Beneficiaries’ Adherence to CMS Star Ratings’ Generic Medications

(9-458) Factors and Bias in Statin Prescribing for Primary Prevention in Patients with Diabetes

(9-459) Evaluating the Efficacy of Text Messaging on Patient Outreach Rates in a Telephonic Ambulatory Care Clinic

(9-460) Pharmacist Impact on the Use of First-Line Antihypertensive Medications in the African American Population

(9-461) Quetiapine Deprescribing Following ICU Discharge

(9-462) Review of a Trauma/Orthopedic Surgery Venous Thromboembolism Prophylactic Dosing Protocol and Institution Compliance at a Level-1 Trauma Center

(9-463) Impact of Pharmacist-led COVID-19 Vaccination Efforts in Transplant Patient Population

(9-464) Evaluation of Dexmedetomidine Utilization Among Critically Ill Patients at a Community Hospital

(9-465) Comparison of the Time to Extubation Between Sugammadex versus Neostigmine in the Operating Room

(9-466) Retrospective Evaluation of Tolvaptan Use for Hyponatremia in a Community Hospital

(9-467) Evaluation of Metformin Prescribing Patterns in Patients with Type 2 Diabetes Mellitus in a Rural Healthcare Setting: Second Phase

(9-468) Common Drug-Drug Interactions in Patients with Atrial Fibrillation Anticoagulated with Factor Xa Inhibitors: Risk Factors for Bleeding - A Case-Control Study

(9-469) Real World Comparison of Voriconazole versus Isavuconazole in Patients with Invasive Aspergillosis

(9-470) Impact of Pharmacists on Empiric Antibiotic Utilization in Patients with Open Fractures

(9-471) Evaluation of Trough-based vs AUC-based Vancomycin Dosing in Number of Initial Therapeutic Vancomycin Levels

(9-472) Days of Intravenous Vancomycin Therapy in Patients with Pneumonia After Negative Methicillin-Resistant Staphylococcus Aureus Nasal Screen During Inpatient Rehabilitation

(9-473) Evaluation of Vitamin D Goal Level Achievement in Brain Injury Patients at an Inpatient Rehabilitation Center

(9-474) Evaluation of Guideline Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction in Patients on Hemodialysis

(9-475) Assessing the Impact of a Dedicated Heart Failure Team on Guideline-Directed Medical Therapy Initiation During Hospitalization

(9-476) Evaluating the Impact of BioFire BCID2 Panel Testing on Time to Appropriate Antimicrobial Selection

(9-477) Evaluation of Initial Gentamicin Dosing Across Three Neonatal Age Groups in a Level III Neonatal Intensive Care Unit

(9-478) Determining the Impact of Transitions of Care Pharmacists on Renal Dose Adjustments During Discharge Medication Reconciliation

(9-479) Evaluation of Outcomes and Adverse Effects with Dexamethasone to Treat COVID-19 in Patients with Elevated C-Reactive Protein Values

(9-480) Evaluation of Fixed Dose Four Factor-Prothrombin Complex Concentrate (4F-PCC) in Patients with Oral Factor Xa Inhibitor-related Hemorrhage

(9-481) Emergency Department Long-acting Glycopeptide Utilization for Simple Cellulitis at a Community Teaching Hospital

(9-482) Evaluation of the Use of Tenecteplase in Acute Ischemic Stroke

(9-483) Fosfomycin Use in Extended Spectrum Beta-lactamase Urinary Tract Infections

(9-484) Increasing Naloxone Prescribing in the Emergency Department Through the Integration of a Cognitive Computing Opioid Risk Model and an Electronic Reminder

(9-485) Evaluation of the Association Between Sleep and Agitation in Traumatic Brain Injury in Rehabilitation

(9-486) Assessment of Prophylactic Antibiotics in Open Fractures at a Level II Trauma Center

(10-001) Effectiveness of a Type 2 Diabetes Panel Management Model Compared to a Referral-Based Model on Glycemic Control in an Ambulatory Care Setting

(10-002) Comparing the Efficacy of Order Panels versus Best Practice Alerts to Influence Dosing Recommendations for Renal Dose Adjusted Medications

(10-003) Increasing Utilization for an Existing Meds to Beds Program: A Quality Improvement Project

(10-004) Comparing the Ability of Community Pharmacists to Screen for Food Insecurity and Educate Qualifying Patients on Available Resources During In-Person and Telephonic Patient Encounters

(10-005) Implementation of a Dexmedetomidine Taper Protocol Utilizing Enteral Clonidine in the Intensive Care Unit

(10-006) Emergency Department Pharmacist Interventions and Associated Cost Avoidance: A Retrospective Analysis

(10-007) Implementation of Institutional Guidelines for the Use of Phenobarbital in Severe Alcohol Withdrawal Syndrome at a Community Hospital

(10-008) Implementation of a Pharmacist-driven Leucovorin Rescue Protocol Following Administration of High-dose Methotrexate in a 330-bed Hospital

(10-009) Assessing Pharmacist-led Perioperative Anticoagulation Management and Outcomes

(10-010) Evaluation of Outpatient Antimicrobial Stewardship in Uncomplicated Cystitis or Pyelonephritis Treatment

(10-011) Assessment of Naloxone Co-prescription Patterns upon Hospital Discharge in a Community Health System

(10-012) Evaluation of Phenobarbital Dosing Strategies in Patients Admitted to the Hospital for Management of Alcohol Withdrawal Syndrome

(10-013) Impact of an Integrated Perioperative Pharmacist Service on Medication Management at a Community Teaching Hospital

(10-014) Emergency Department Alcohol Withdrawal Panel Implementation

(10-015) Clinical Decision Support Tool Implementation: Diuretic Use with Critically High or Low Potassium Levels

(10-016) Development and Implementation of a QTc Interval Monitoring Program Within a Health System: A Process Improvement Project

(10-018) Effect of High vs. Low Dexmedetomidine Doses in Post-Operative Cardiothoracic Surgery Patients

(10-019) Double Strengths versus Single Strength Bactrim for the Prophylaxis of Urinary Tract Infections in Kidney Transplant Patients

(10-020) Reduced Dosing Strategies Compared to Conventional Dosing for Therapeutic Enoxaparin in Critically Ill Patients

(10-021) Ketorolac Use for Pain Management in Trauma Patients with Orthopedic Fractures

(10-022) Comparison of Diltiazem Immediate versus Extended Release in Sustaining Acute Rapid Ventricular Response Rate Control

(10-023) Accuracy of Methicillin-resistant Staphylococcus Aureus Colonization Detection Methods to Predict MRSA Skin and Soft Tissue Infections

(10-024) Evaluation of Tacrolimus Trough Level Variability Among Cardiac Transplant Recipients Receiving Renal Replacement Therapy at a Pediatric Hospital

(10-025) Efficacy of Rifaximin Prophylaxis for Bloodstream Infections in Parenteral Nutrition Dependent Pediatric Patients with Short Bowel Syndrome

(10-026) Efficacy and Safety of 5 Units versus 10 Units Intravenous Insulin for the Treatment of Hyperkalemia

(10-027) Evaluating Appropriateness, Adverse Effects, and Financial Impact of Inpatient Chemotherapy Use

(10-028) Time to Antibiotic De-escalation for Community-acquired Acute Uncomplicated Cystitis Utilizing a Pharmacist-driven De-escalation Algorithm

(10-029) Impact of Transitions of Care (TOC) Pharmacy Services on Patients with Congestive Heart Failure (CHF)

(10-030) Impact of Phenobarbital Added to Benzodiazepines for Patients Admitted to the Intensive Care Unit (ICU) with Alcohol Withdrawal

(10-031) Ceftriaxone with Metronidazole versus Antipseudomonal Antibiotics in Intraabdominal Infections: A Single - Center, Retrospective Cohort Study

(10-032) Assessing Appropriate Epoetin Alfa Use in a Community Hospital

(10-033) Evaluation of International Normalized Ratio Correlation Among Patients with Antiphospholipid Syndrome in Pharmacist Managed Anticoagulation Clinics

(10-034) Assessment of Current Prescribing Patterns of Methylnaltrexone: A Medication Utilization Evaluation

(10-035) Effectivenes​​s of Pharmacist-Led Medication Reconciliation in the Emergency Department and Telemetry Unit

(10-036) Comparison of Time to Appropriate Antibiotic Therapy Before and After Implementation of ePLEX Blood Culture Identification (BCID) Panels

(10-037) The Implementation and Impact of Clinical Pharmacy Services in an Interdisciplinary Internal Medicine Clinic

(10-038) Estimated Cost Savings Associated with Implementing an Institutional Policy Defining Appropriate Inpatient Chemotherapy Criteria

(10-039) Impact of a Rapid Respiratory Panel on Duration of Empiric Antibiotics in General Medicine Patients at a Community Hospital

(10-040) Analysis of Antibiotic Utilization Trends for Prevention of Spontaneous Bacterial Peritonitis in Patients with Cirrhosis of the Liver

(10-042) Evaluation of Institutional Practice versus Pediatric Community Acquired Pneumonia Guideline Recommendations

(10-043) Implementation of a Fixed Dose Intensive Care Unit Fentanyl Infusion Protocol

(10-044) Cost Savings Analysis of Twice Daily Pantoprazole Bolus Therapy versus Continuous Infusion for Upper Gastrointestinal Bleeds

(10-045) Evaluation of Epoetin Alfa-epbx Use via Subcutaneous Administration vs. Intravenous Administration

(10-046) Anti-Xa vs. aPTT: Evaluation of Heparin Monitoring Strategies

(10-047) Impact of Concurrent Pharmacist Review and Intervention on CMS SEP-1 Core Measure Compliance in the Emergency Department

(10-048) Assessing Compliance to a Pharmacist Driven IV to PO Conversion Protocol: A Medication Use Evaluation

(10-049) Evaluation of a Meds to Beds Program in Pediatric Patients

(10-050) Real-World Efficacy of Long-Acting Cabotegravir and Rilpivirine in an Urban HIV Clinic

(10-051) Efficacy Profile of Glucagon-Like Peptide-1 (GLP-1) Agonists for Patients with Type 2 Diabetes Mellitus (T2DM) in a Safety Net Health System

(10-052) Time to Administration of Post-intubation Analgesia and Sedation Before and After a Quality Improvement Initiative

(10-053) Initiation of Continuous Infusion Neuromuscular Blocking Agents for Severe Acute Respiratory Distress Syndrome

(10-054) Vasopressin 0.03 Units/min versus 0.04 Units/min in Patients with Septic Shock

(10-055) Evaluation of Intravenous to Oral Conversion of Antihypertensives in Hypertensive Emergencies

(10-056) Evaluating Appropriate Use of Hydroxocobalamin Administration at Loyola University Medical Center

(10-057) Evaluation of Systemic Alteplase Vial Size Selection in Doses of 50 Mg or Less

(10-058) Utilization of Sugammadex Outside of the Operating Room

(10-059) Adherence to Fixed-Dose 4-Factor Prothrombin Complex Concentrate (4FPCC)

(10-060) Evaluation of EndoTool and Adverse Events in Patients Within Loyola University Medical Center

(10-061) Incidence of Vancomycin-Induced Nephrotoxicity and Estimation of Vancomycin Exposure in a Hospitalized Adult Population

(10-062) Evaluation of Use of Ceftriaxone in Hospitalized Pediatric Patients

(10-063) Duration of Valganciclovir for Cytomegalovirus Prophylaxis in Lung Transplant Recipients: A Single Center Analysis

(10-064) Opportunities for Pharmacists to Improve Anticoagulation Dosing and Monitoring Following Discharge at a Community Hospital

(10-065) Antibiotics for Facial Fractures: Does Duration Matter?

(10-066) Buprenorphine/Naloxone Utilization in Transitions of Care

(10-067) Evaluate the Use of Dexmedetomidine for Sedation in the Intensive Care Unit

(10-068) Evaluation of the Use and Appropriateness of Intravenous Antihypertensive Infusions in an Urban Safety Net Hospital

(10-069) Evaluation of Discharge Antibiotic Prescription Adherence to Infectious Disease Consultant Recommendations

(10-070) Evaluation of Pharmacist Dispensing Workflow for Nirmatrelvir/Ritonavir at a Health System-Based Outpatient Pharmacy

(10-071) Evaluation of Two Aspirin Doses for VTE Prophylaxis

(10-072) Evaluation of Revenue Lost from Medications Administered by the Anesthesia Department in Areas Without an Automated Dispensing System

(10-073) Evaluation of Andexanet Alfa Ordering and Administration Within a Community Health System

(10-074) Discontinuation of Heparin Products with a Pending Heparin-Induced Thrombocytopenia Antibody Test

(10-075) Evaluation of Antimicrobial Selection for the Acute Treatment of Sexually Transmitted Infections in the Emergency Department

(10-076) Early Administration of Scheduled Medications

(10-077) Evaluation of Pain Score and Opioid Consumption with Bupivacaine-Meloxicam Extended-Release Solution in Primary Total Knee Arthroplasty

(10-078) Single-Dose Gentamicin in the Emergency Department for Acute Uncomplicated Cystitis

(10-079) Evaluation of Enteral Protein Supplement Documentation Adherence

(10-080) Evaluation of Hyperglycemia Management in Pancreatic Cancer Patients

(10-081) Assessment of Delayed Physical Therapy Evaluation and Length of Stay for Total Joint Replacement Patients

(10-082) Opioid and Benzodiazepine Prescribing Practices at a Multi-Centered Health System

(10-083) Evaluation of Enoxaparin Refusal for Venous Thromboembolism Prophylaxis in High Risk Caprini Score Patients

(10-084) Rate of Unintentional Medication Discrepancies in Medication Histories Obtained by Both Pharmacy and Nursing Staff Compared to Only Pharmacy Staff: A Pre-Post Study

(10-085) Evaluation of the Safety of a Beta-Lactam Allergy Protocol

(10-086) Evaluation of the Utilization of Intravenous Iron Sucrose at a Non-Teaching Community Hospital

(10-087) Comparing Aerobic versus Anaerobic Coverage in Patients with Aspiration Pneumonia

(10-088) Evaluation of Second Phase Anti-Epileptic Therapies for Status Epilepticus

(10-089) Evaluation of Antibiotic Prophylaxis Timing in Trauma Patients with Open Fractures with an Emergency Medicine Pharmacist

(10-090) Evaluation of Pharmacological Treatment of Acute Agitation and Aggression in Hospitalized Pediatric Patients

(10-091) Utilization of Dispense Tracking to Reduce Re-dispensing

(10-092) Review of Emergency Department Prescribing Practices for Acute Uncomplicated Cystitis at Springfield Memorial Hospital

(10-093) Evaluation of Parenteral Glucagon Administration in the Emergency Department for Esophageal Foreign Body Impaction

(10-094) Empagliflozin and Dapagliflozin in Heart Failure with Reduced Ejection Fraction

(10-095) Let’s Take a Time-out: Implementing a Standardized Process to Assess the Clinical Use of Vancomycin for Pharmacists

(10-096) Evaluating the Efficacy and Safety of High-Dose Heparin for Prophylaxis of Venous Thromboembolism in Morbidly Obese Hospitalized Patients

(10-097) HIV PrEP: Missed Need at an Urban, Academic, Medical Center?

(10-098) Co-Prescribing of Naloxone in the Outpatient Clinical Setting Following Implementation of a Free Take Home Naloxone Program

(10-099) Lipid Lowering Therapy in Patients Following Acute Myocardial Infarction

(10-100) Tolerability of Rapid Initiation versus Traditional Sequencing of Guideline Directed Medical Therapy in Newly Diagnosed Patients with Heart Failure with Reduced Ejection Fraction

(10-101) Use of Alternative to Opioids to Control Sickle Cell Crisis Pain for Patients Admitted to UI Health

(10-102) Efficacy and Safety of Perioperative Angiotensin II versus Catecholamines as a First-line Vasopressor in Kidney Transplant Recipients

(10-103) Evaluation of the Antibiotic Spectrum Utilized in Open Fractures at Level I Trauma Centers

(10-104) Impact of a Pharmacist-Driven Medication Therapy Management Clinic on 30-Day Readmission Rate

(10-105) Pharmacist-Driven De-escalation Protocol for Urine Cultures and Sexually Transmitted Infections in the Emergency Department Increases Antibiotic-free Days

(10-106) The Use of Belatacept in Pancreas Transplantation to Halt Progression of Calcineurin Inhibitor-Induced Nephrotoxicity

(10-107) The Use of LCP Tacrolimus versus Immediate Release Tacrolimus in Simultaneous Pancreas-Kidney Transplantation

(10-108) Pain Control for Acute Pancreatitis on General Medicine for Patients Admitted to UI Health

(10-109) Answering the Burning Question: Calcium Chloride versus Gluconate for Hyperkalemia

(10-110) Comparison of Safety Outcomes Between Weight-Based and Fixed-Dose Prednisone Taper Dosing Strategies After Kidney Transplant

(10-111) Timing of Hydrocortisone Discontinuation in Patients with Septic Shock

(10-112) Evaluation of Midodrine Use in Critically Ill Patients Requiring Intravenous Vasopressors

(10-113) Justification of a Pharmacist-led Collaborative Hypertension Management Service in a Health-System Owned Primary Care Clinic

(10-114) Relationship Between Ceftriaxone and Hypoalbuminemia and Potential Impact on Clinical Dosing Strategies

(10-115) Evaluation of Antimicrobial Use in Patients with ESBL-producing Enterobacterales Cystitis

(10-116) Gastrointestinal Bleeds in Patients Receiving Therapeutic Anticoagulation with Direct Oral Anticoagulants or Warfarin: Evaluation with Odds Ratios of Patient Characteristics

(10-117) Advancing Inpatient Mental Health Treatment: Evaluating and Enhancing Current Inpatient Practice for Patients Requiring Secondary Mental Health Treatment in a Small Community Hospital

(10-118) Implementation of a Revised Hospital Protocol for Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar State (HHS) to Improve Patient Outcomes Through Enhanced Nursing Autonomy

(10-119) Assessing the Incidence of Cefepime-Induced Neurotoxicity in Adults in an Inpatient Setting

(10-120) Assessing Inpatient Pharmacist Competency and Confidence in the Management of Neonatal Total Parenteral Nutrition

(10-121) Comparison of the Efficacy and Safety of Different Vancomycin Dosing Strategies in the Obese Patient Population

(10-122) Utility of Quantitative Lower-Respiratory Tract Cultures in De-escalating or Discontinuing Antibiotics in Ventilator-Associated Pneumonia

(10-123) Evaluation of Potassium Replacement Practices in a Pediatric Hospital

(10-124) Impact of a Pharmacy-driven Vaccination Intervention in Adult Warfarin Patients Managed in an Ambulatory Medication Management Clinic

(10-125) Comparison of Three Models for Predicting Drug Resistant Pathogens in Patients with Community-acquired Pneumonia in a Community Hospital

(10-126) Impact of Pharmacist-Driven Time to Antibiotic Administration for Septic Patients in the Emergency Department

(10-127) Efficacy of Continuous Glucose Monitoring on Glycemic Control in Adults with Type 2 Diabetes

(10-128) Retrospective Analysis of Opportunities to Convert from Warfarin to a Direct Oral Anticoagulant for Chronic Anticoagulation Therapy

(10-129) Evaluating Emergency Department Broad Spectrum Antibiotic Use: Analysis of Changes Made to Antibiotic Therapy Within 24 Hours of Hospital Admission

(10-130) Retrospective Study on the Continuation of Buprenorphine in the Perioperative Setting

(10-131) Comparison of Buprenorphine Induction with or Without Full Agonist in Patients Admitted to a Community Psychiatric Facility: A Retrospective Chart Review

(10-132) Implementation of a Pharmacy Discharge Medication Review Pilot

(10-133) Implementation of Penicillin Allergy Testing Pilot in a Health System: Phase II

(10-134) Evaluation of Community Acquired Pneumonia Treatment Transitions of Care in a Community Health System

(10-135) Therapeutic Assessment of High-Dose Initial Heparin Infusion for Patients in Stroke Therapy Protocol at Community Hospital

(10-136) Evaluation of Urine Culture Follow-Up in a Community Hospital Emergency Department

(10-137) Assessment of Pharmacy Consult Service on Clostridium Difficile Infection Rates Within Community Healthcare System

(10-138) Assessment of Medications Utilized for Treatment of Chemotherapy-Induced Nausea and Vomiting at Community Health System

(10-139) Comparison of Oral Phenobarbital to Chlordiazepoxide Protocol for Alcohol Withdrawal

(10-140) High-Dose versus Low-Dose 4-Factor Prothrombin Complex Concentrate for Reversal of Direct Acting Oral Anticoagulants in Intracranial Hemorrhage

(10-141) Development of Training Procedures for Hazardous Drug Compounding

(10-142) Improving Medication Reconciliation Technician Training and Education Through Performance Audits, Training Updates, and Educational Review

(10-143) Evaluating the Appropriateness of Warfarin Therapy in Patients Enrolled in Anticoagulation Clinic

(10-144) Evaluation Of glycemic Control with Continuous Glucose Monitoring vs. Traditional Blood Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Managed by Ambulatory Care Pharmacists

(10-145) Evaluating the Efficacy of Empagliflozin in Patients with Heart Failure with Reduced Ejection Fraction

(10-146) Comparison of Two Testing Strategies for Mycoplasma Genitalium in Emergency Department Patients

(10-147) Evaluation of Pseudomonas Aeruginosa Piperacillin/Tazobactam Resistance Testing Methods

(10-148) Assessment of Gestational Diabetes Management in an Obstetrics and Gynecology Clinic for Collaborative Care

(10-149) Pharmacy Technician-Lead Refill Authorization Service Team: Patient and Provider Impact Across Multiple Practices

(10-150) Establishing Team-Based Weight Management Services in Primary Care Clinics

(10-151) Implementation of a Pharmacist-to-pharmacist Transitions of Care Protocol for Patients with Chronic Obstructive Pulmonary Disease and Diabetes Mellitus

(10-152) Comparison of the Use of SGLT2i and GLP1RA in Patients with Diabetes Managed by PCP Alone vs Patients Co-managed by a Pharmacist

(10-153) Assessment of Antibiotic Utilization in Sepsis Order Sets Initiated in the Emergency Department

(10-154) Decreased Heparin Bolus Leads to Decreased Bleeding with Impella® 5.0 or 5.5 Insertion

(10-155) Implementation of a Pharmacist-Led Culture Callback Protocol in the Emergency Department

(10-156) Pharmacist Transitions of Care Telephonic Outreach Reduced Hospital Readmission Rates for Medicare and Medicaid Patients

(10-157) Continuation of Critical Care Infusion Orders After Intensive Care Unit Discharge on Weekdays versus Weekends and Rate of Pharmacist Intervention

(10-158) Effect of Education to Medical Staff on Prescribing Patterns of Antibiotic Therapy in Aspiration Pneumonia

(10-159) Impact of Pharmacist-Led Direct Oral Anticoagulant (DOAC) Monitoring on Appropriate Medication Use

(10-160) Comparison of Clinical Pharmacist versus Nurse Led Medicare Annual Wellness Visits in the Primary Care Clinic Setting

(10-161) Evaluation of Intravenous Loop Diuretic Use in Acute Decompensated Heart Failure in a Community Hospital

(10-162) Characterizing Appropriate Use of Octreotide Continuous Infusions for Gastroesophageal Bleeding

(10-163) Medication Use Evaluation of Angiotensin II

(10-164) Efficacy and Safety of 10,000 Unit Unfractionated Heparin Boluses for Acute Myocardial Infarction in the Emergency Department

(10-165) Impact of Specialty Pharmacy Services on Pneumococcal Vaccination Rates in a Large Inflammatory Bowel Disease Population

(10-166) Measurement of Medication Therapy Intervention and Optimization Opportunities at an Interdisciplinary Anticoagulation Clinic

(10-167) Assessing the Appropriateness of Antibiotic Selection and Therapy Duration in the Management of Urinary Tract Infections in a Community Hospital Setting

(10-168) Evaluating the Use of Dalbavancin to Reduce Hospital Admissions and Inpatient Days of Therapy for Acute Bacterial Skin and Skin Structure Infections

(10-169) Urinalysis and Urine Culture Ordering Pattern in the ED

(10-170) Efficacy of Potassium Binders in the Management of Acute Hyperkalemia in the Emergency Department: A Retrospective, Cohort Study

(10-171) Quality Improvement of Utilizing Union Hospital’s Outpatient Pharmacy to Process Patient Prescriptions upon Discharge

(10-172) Comparison of International Guidelines in the Management of Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Its Associated Burden

(10-173) Impact of COVID-19 on the Incidence and Risk Factors of Clostridioides Difficile in a Lebanese Tertiary Care Hospital: A Retrospective Pre/post Study

(10-174) Assessing Vancomycin Area Under Curve (AUC) Guided Monitoring Strategy in Adult and Pediatric Patients in a Lebanese Tertiary Hospital: A Pre/Post Retrospective Study

(10-175) Evaluation of the Frequency in Which Warfarin Was Adjusted After Nirmatrelvir/ritonavir Was Initiated in Patients Enrolled in a Pharmacist-managed Anticoagulation Clinic

(10-176) Impact of Health Literacy on Multiple Patient Variables: A Single-Center Observational Study in Lebanon

(10-177) Pharmacist-Led Medication Reconciliation upon Discharge from the Orthopedic Surgery Department

(10-178) Trends of Antidotes Utilization in Poisoning Cases at a Tertiary Care Hospital

(10-179) Medication Use Evaluation of Deferasirox

(10-180) Appropriateness of Direct Acting Oral Anticoagulant Prescriptions in Patients with Atrial Fibrillation: Data from United Arab Emirates

(10-181) Correlation Between AUC and Trough Level of Vancomycin in Adult Patients with MRSA Infections

(10-182) Assessing the Appropriateness of Proton Pump Inhibitors Use in non-ICU Hospitalized Patients

(10-183) Prevalence of Potentially Inappropriate Medication Use Among Pediatrics Using the KIDs List

(10-184) Improving Collaboration Between Inpatient Pharmacy and Discharge Pharmacist Through Medication Reconciliation Streamlining During the Admissions Process

(10-185) Evaluating the Use of Dextrose 10% Solution (D10) versus Dextrose 50% Solution (D50) in the Treatment of Hypoglycemia in Hospitalized Patients

(10-186) Comparison of Treatment Failure Rates Between Outpatient Antibiotic Regimens in Patients with Uncomplicated Diverticulitis

(10-187) Evaluating the Clinical Impact of Pharmacist-led Culture Review in a Community Hospital Emergency Department

(10-188) Risk Factors and Causes of Hypoglycemia in a Hospitalized Patient

(10-189) Assessment of Efficacy and Adherence to a Nurse-Managed Protocol for Electrolyte Repletion in Hospitalized Patients

(10-190) Impact of Pharmacist-Prescribed Ritonavir-Boosted Nirmatrelvir for Coronavirus Disease 2019 (COVID-19) Treatment on Patients and Pharmacy Operations

(10-191) A Multidisciplinary Quality Improvement Project to Increase Chlamydia and Gonorrhea Screening in a Family Medicine Clinic

(10-192) Evaluation of Pharmacist Driven Anti-Xa Monitoring of Enoxaparin in Obesity, Renal Disease, and COVID-19

(10-193) Development of a Screening Tool for Opioid-Induced Endocrinopathy in Adult Patients

(10-194) Doxycycline as an Alternative for Prophylaxis for Urea-plasma Species Bacteria in a New Lung Transplant Patient with QTc Prolongation

(10-195) Resistance Patterns of Gram-Negative Pathogens in Late-Onset Sepsis in NICU Patients

(10-196) Rehospitalizations Following Initiation of Paliperidone Palmitate

(10-197) Evaluation of Tenecteplase versus Alteplase for Treatment of Acute Ischemic Stroke

(10-198) Evaluation of a Phenobarbital Dosing Strategy for Alcohol Withdrawal in the Emergency Department

(10-199) Frequency of Direct LDL-C Measurement Follow-up in Patients with Diabetes and Elevated Triglycerides Within Ambulatory Care Clinics

(10-200) Assessment of Provider Perceptions and Knowledge of Evidence-based Obesity Treatment in the Primary Care Setting

(10-201) Retrospective Evaluation on the Addition of Vasopressin to Initial Pressor Therapy Dosed by Actual versus Adjusted Body Weight

(10-202) Effects of Fixed Dose vs. Weight-Based Tocilizumab Dosing on Escalation of Oxygen Support in Patients with SARS-CoV-2 Infection

(10-203) Impact of Antibiotic Susceptibility Reporting on Carbapenem Usage in ESBL-positive Urine Cultures

(10-204) Assessing the Impact of an Intravenous Room Technology-assisted Workflow System on Cost, Workflow, and Patient Safety in a Regional Health-system

(10-205) Frequency of Therapeutic Drug Monitoring for Narrow Therapeutic Index Drugs in Primary Care

(10-206) Evaluation of Current Prescribing Practices for Uncomplicated Urinary Tract Infections in the Emergency Department at a Community Hospital

(10-207) Evaluating the Effect of Preoperative Fosaprepitant Compared to Standard of Care Antiemetics on Length of Stay in Patients Undergoing Bariatric Surgery

(10-208) Impact of an Outpatient Anticoagulation Clinic on Time Within Therapeutic INR Range

(10-209) Implementation of an Electrolyte Replacement Protocol in the Intensive Care Unit

(10-210) Antibiotic Optimization with a Multiplex Polymerase Chain Reaction System vs. Traditional Cultures in Sepsis

(10-211) Anticoagulation Discharge Education by Pharmacists and Its Impact on Readmission Rates in a Large Community Hospital

(10-212) Bivalirudin vs Argatroban: Evaluating Time to First Therapeutic Activated Partial Thromboplastin Time (aPTT) Level and Ease-Of-Use

(10-213) Assessing Pharmacist Intervention on the Co-Prescribing of Benzodiazepines and Multiple Opioids at Discharge

(10-214) Evaluation of Early Subcutaneous Long Acting Insulin Administration During Diabetic Ketoacidosis in the Pediatric Population

(10-215) Retrospective Evaluation of a Fixed Dose Prothrombin Complex Concentrate Reversal Strategy for Major Bleeding on Factor Xa Inhibitors

(10-216) Evaluation of Achieving A1c Goals with Pharmacy Management Compared to Standard of Care

(10-217) Characterization of Antibiotic Prescribing for Common Infectious Disease States at Hospital Discharge

(10-218) Retrospective Study Assessing the Accuracy of Carboplatin Dosing Using Actual versus Adjusted Body Weight and Actual versus Rounded Serum Creatinine

(10-219) Assessment of High-Intensity Heparin Dosing and Bleeding in Patients with Deep Vein Thrombosis or Pulmonary Embolism in an Acute Care Intensive Care Unit

(10-220) Time to Resolution of Neutropenia with and Without Therapeutic Granulocyte Colony-Stimulating Factors

(10-221) Phytonadione Utilization and the Risk of Bleeding in Chronic Liver Disease

(10-222) Effects of Sodium Bicarbonate on Time to Anion Gap Closure in Diabetic Ketoacidosis

(10-223) Early Basal Insulin Administration in Diabetic Ketoacidosis

(10-224) Antiepileptic Drug Practices During the Management of Traumatic Brain Injury: A Multicenter Survey Study

(10-225) Association of Prothrombin Complex Concentrate Administration Timing on Hemostasis Achievement in Warfarin-Associated Intracranial Hemorrhage

(10-226) Impact of Pharmacist Order Verification of Pediatric Medications in the Emergency Department

(10-227) Implementing Inclisiran in Pharmacist-Led Medication Management Clinic

(10-228) Expansion of Lipid Lowering Therapy Optimization During Transitions of Care in Post-acute Myocardial Infarction (AMI) Patients

(10-229) Retrospective Evaluation of Paclitaxel Hypersensitivity Reactions at a Multicenter Health System

(10-230) Impact on Heart Failure Readmission Rates Through Pharmacist Driven Guideline Mediated Management and Titration in a Heart Failure Clinic

(10-231) Clinical Outcomes of Incretin Mimetic Drugs Used for Weight Loss in a Pharmacist Run Clinic

(10-232) Impact of Pharmacist Involvement and Management in Patients with Diabetes That Are Enrolled in an Outpatient Endocrinology Clinic

(10-233) Use of Clonidine to Wean Dexmedetomidine in a Community Hospital

(10-234) Evaluation of the Safety and Efficacy of Tenecteplase versus Alteplase for Treatment of Acute Ischemic Stroke in a Community Hospital Setting

(10-235) Optimizing Workflow for Sterile Compounding Pharmacy Technicians in an Inpatient Pharmacy

(10-236) Evaluation of Patient Outcomes Related to the Receipt of Alteplase versus Tenecteplase for Acute Ischemic Stroke in a Community Hospital

(10-237) Evaluation of Scheduled versus Nursing-driven Electrolyte Replacement on Adherence to Replacement Protocols in a Community Hospital Setting

(10-238) Evaluation of Cephalosporin Use After Pharmacist-driven Education on Beta-lactam Allergy Cross-reactions and Electronic Health Record Alert Suppression in a Community Hospital

(10-239) Evaluation of the Effect of Pharmacy-driven Education and Peer Comparison on the Amount of Opioids Prescribed in a Community Hospital

(10-240) Evaluation of the Incidence of Hypoglycemia After Implementation of an Electronic Glucose Monitoring System in a Community Hospital Setting

(10-241) Use of Remote Patient Monitoring Kits to Reduce Hospitalization and Mortality Rates for Patients with Heart Failure

(10-242) Effect of Computerized Glycemic Management Systems on Time to Resolution of Diabetic Ketoacidosis

(10-243) Incidence of Rituximab Infusion Reactions in Rituximab Primed vs Saline Primed Lines

(10-244) Epidural-Induced Hypotension During Labor and Delivery: Incidence and Risk Factors

(10-245) Evaluating Outcomes of Pharmacist-Driven Intervention on Total Parenteral Nutrition Management

(10-246) Impact of a Discharge Medication Delivery Service Program on Readmission Rates in Patients with Heart Failure and Acute Myocardial Infarction

(10-247) Evaluation of Bispectral Index Monitoring in Patients Receiving Concomitant Paralytics and Ketamine

(10-248) Impact of Baseline Procalcitonin Ordering in the ED on Antimicrobial Discontinuation in Patients with Sepsis at a Rural Community Health System

(10-249) Impact of Clinical Decision Support Tools on the Optimization of Ceftriaxone Dosing in Patients with Bacteremia in a Rural Community Health System

(10-250) Effect of Weight-based Norepinephrine vs. Non-weight-based Norepinephrine Dosing on Total Vasopressor Requirements; A Retrospective Cohort Study

(10-251) Selection of Optimal Antihyperglycemic Regimen Study (SOAR Study)

(10-252) Analysis of Patient Outcomes Involving a Pharmacy Driven Modification of Dopamine Utility Within Institutional Code Boxes

(10-253) Comparison of Alcohol-Based Nasal Antiseptic to Mupirocin for MRSA Decolonization in Orthopedic Surgery

(10-254) Evaluation of Discharge Warfarin Regimens in Patients with a Supratherapeutic International Normalized Ratio (INR) on Admission

(10-255) Appropriate Justification of Multiple Antipsychotic Use at Discharge Following Inpatient Admission

(10-256) Prescribing Compliance with Guideline Directed Medical Therapy for American College of Cardiology/AHA Heart Failure Guidelines

(10-257) Analyzing Appropriate Sedation Regimens for Mechanically Ventilated Patients Based on Their COVID – 19 Status

(10-258) Assessing the Impact of Fluid Resuscitation Timing in Hypotensive Septic Patients

(10-259) Evaluation of Quetiapine Monotherapy vs Quetiapine Plus Oxazepam for ICU Agitation on Post-Extubation ICU Length of Stay

(10-260) Impact of Lactate Clearance Rate and Lactate Normalization on Hospital Length of Stay in Patients with Septic Shock

(10-261) Impact of Pharmacist-Managed Diabetes Medication at a Chronic Care Clinic in a Rural Community

(10-262) Comparison of Pharmacist versus Other Health Care Provider’s Nirmatrelvir/Ritonavir Prescribing Habits in a Rural Health Care System

(10-263) Enteral Naloxone Verses Methylnaltrexone Use for Refractory Constipation

(10-264) Analysis of Blood Pressure Management Post Alteplase Administration for Acute Ischemic Stroke

(10-265) Assessment of Steroid Utilization Throughout a Community Health System

(10-266) Intravenous Push Antibiotics in the Emergency Department: Education and Implementation

(10-267) Pharmacist Driven Optimization of Automated Dispensing Cabinet Inventory

(10-268) Implementation of the Khorana Score for Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Oncology Patients at a Community Cancer Center

(10-269) Implementation of Controlled Substance Diversion Monitoring Software in a Community Health System

(10-270) Evaluation of Hyponatremia Practices Within a Community Healthcare System

(10-271) Continuation Rates for Proton Pump Inhibitors After a Duration Limit Change in Medicaid Formulary

(10-272) Pharmacist-initiated Naloxone Dispensing in Patients New to Hepatitis C Virus (HCV) Treatment

(10-273) Evaluation of Enoxaparin for Venous Thromboembolism Prophylaxis in Underweight Patients

(10-274) Assessing the Need for a Pharmacist-Led Warfarin Dosing Service in a Community-Based Academic Medical Center

(10-275) Evaluation of Sodium Bicarbonate-based versus Dextrose-based Purge Solution for Impella

(10-276) Evaluation of Adherence to a Rapid Infusion Infliximab Protocol at an Academic Health System

(10-277) Assessing the Impact of Albumin in Addition to Loop Diuretics on Fluid Deresuscitation in Septic Shock Patients in the Intensive Care Unit

(10-278) Impact of a Clinical Pharmacist on the Prevention and Management of Diabetic Kidney Disease in an Ambulatory Care Setting

(10-279) Efficacy and Safety of Dapagliflozin in Hospitalized Patients with Acute Heart Failure

(10-280) The Effects of Music Therapy on Patients Undergoing Procedural Sedation with Ketamine in the Emergency Department

(10-281) Impact of Ustekinumab Trough Levels on Clinical Outcomes in Patients with Inflammatory Bowel Disease

(10-282) Impact of Elexacaftor/tezacaftor/ivacaftor(ETI) on Sputum Collection and Subsequent Culture Results in Adult Cystic Fibrosis(CF) Clinic

(10-283) Evaluation of the Impact of an Emergency Medicine Pharmacist on Antimicrobial-related Sepsis Metrics Within a Community Emergency Department

(10-284) Use of Letermovir for CMV Prophylaxis in High-risk Allogeneic HCT Recipients

(10-285) An Evaluation of the Clinical Significance of Coadministering Moderate to Strong Cytochrome P450 Enzyme Inhibitors with Doxorubicin

(10-286) Characterization of Loop Diuretic Use in Critically Ill Trauma Patients with Positive Fluid Balance

(10-287) Impact of Bodyweight on Hemodynamics in Critically Ill Patients Receiving Propofol

(10-288) Evaluation of Combination Sedation Therapy with Propofol and Dexmedetomidine in the Intensive Care Unit

(10-289) Impact of Manual versus Automated QT/QTc on Antimicrobial Stewardship

(10-290) Evaluation of Clinical Inertia in Patients Living with Type 2 Diabetes Within a Federally Qualified Health Center

(10-291) Impact of Post-Myocardial Infarction (MI) Depression on Cardiovascular-Related Hospitalizations

(10-292) Evaluation of Secondary Therapy Loading Doses in Critically Ill Patients Presenting with Status Epilepticus

(10-293) Evaluation of Pharmacy Intervention’s Impact on Prescribing Practices for Treatment of Urinary Tract Infections (UTIs) from a Hospital Assessment Center

(10-294) Assessing the Impact of a Pharmacist Driven Discharge Counseling Service on 30-day Heart Failure Readmission Rates

(10-295) Pharmacist Impact on Quality Outcomes in Patients Presenting with Sepsis to the Emergency Department

(10-296) Changes in Treatment Outcomes Post-Implementation of a Pediatric Skin and Soft Tissue Infection Clinical Guideline

(10-297) Evaluation of Corticosteroid Therapy and Length of Hospitalization in Patients with Chronic Obstructive Pulmonary Disease Exacerbation

(10-298) Evaluation of High vs Low Dose Levetiracetam for Early Post-Traumatic Seizure Prophylaxis in Patients with Traumatic Brain Injury

(10-299) Evaluation of Clonidine Use for Dexmedetomidine Weaning in Patients Admitted to the Trauma Service

(10-300) Evaluation of the Utilization of Total Phenytoin Levels in Patients with Hypoalbuminemia and Renal Dysfunction at a Single-Center Academic Medical Center

(10-301) Hyperglycemia Management in Non-Critically Ill Patients with Type 2 Diabetes Using Correctional Insulin Only vs. Basal Bolus Regimen

(10-302) Safety of Enoxaparin versus Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Critically Ill Patients with Renal Impairment

(10-303) Evaluation and Implementation of Pharmacist-Driven Medication Reconciliation in High-Risk Surgical Oncology Patients

(10-304) Incidence of Hypertriglyceridemia in ICU Patients Undergoing Continuous Propofol Infusions

(10-305) R.E.C.K vs Exparel: Outcomes, Advantages, and Cost

(10-306) Continuation Rate of Antipsychotics Initiated in the Intensive Care Unit at Discharge

(10-307) Evaluation of Fluconazole Utilization at a Large Academic Medical Center in Southeastern Louisiana

(10-308) Identifying Barriers to the Utilization of Intravenous Pump-System's Safety Software

(10-309) Mouth of the South: Incidence of HPV-Associated Oropharyngeal Cancer and Correlated Socio-demographic Factors

(10-310) COVID-19 Monoclonal Antibody (mAb) Administration Outcomes in a Rural Health-system

(10-311) Reticulocyte Hemoglobin Content to Guide Iron Supplementation Dosing in Neonates with Anemia of Prematurity

(10-312) Phenobarbital Serum Concentrations in Hospitalized Patients with Alcohol Withdrawal Syndrome

(10-313) Evaluation of a Burn Pain and Sedation Clinical Practice Guideline: A Before-and-After Study

(10-314) Effect of Appropriateness of Antimicrobial Regimens at Discharge on Global Patient Outcomes

(10-315) Intravenous Immunoglobulin Use in Kidney Transplant Recipients with Severe Hypogammaglobulinemia